Relapsing Remitting Multiple Sclerosis Patients Initiated on Oral Dmf Report A Better Quality of Life Compared to Patients on Platform Therapies As Measured By Eq-5d.
Iyer R, Jones E, Rana J, Petrillo J, Lee A, Pike J
Value Health. 2015 Nov; 18(7):A762. Epub 2015 Oct 20. PMID: 26534268.Abstract